From CNBC: 2024-10-30 16:01:48

Novo Nordisk’s Wegovy and Ozempic now available in all doses in the U.S., FDA drug shortage update reveals. Supply ramp-up efforts paying off amid high demand. FDA may remove semaglutide injections from shortage list, potentially blocking compounding pharmacies from making cheaper versions. Novo Nordisk prioritizing patient care despite occasional shortages, gradually increasing supply. Company asks FDA to ban unapproved versions of its medications. Eli Lilly’s Zepbound and Mounjaro no longer on FDA shortage list.



Read more at CNBC: Novo Nordisk’s Ozempic, Wegovy now available after shortages